questionText: To ask the Secretary of State for Health and Social Care, what steps the Medicines and Healthcare products Regulatory Agency is taking to improve clinician reporting of myocarditis and pericarditis in the Yellow Card system; and whether the Department has assessed under‑reporting rates for these conditions.
answerText: The Medicines and Healthcare products Regulatory Agency (MHRA) is committed to continually strengthening the Yellow Card scheme to support patient safety. The MHRA regularly promotes awareness through public health campaigns, conferences, established netw...
heading: Heart Diseases: Yellow Card Scheme